Novartis sells parts of Sandoz U.S. to India's Aurobindo for $900 million

Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India’s Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.

Source:: http://feeds.reuters.com/~r/reuters/businessNews/~3/zxFPeSxkVf4/novartis-sells-parts-of-sandoz-u-s-to-indias-aurobindo-for-900-million-idUSKCN1LM0D4